Navigation Links
Boehringer Ingelheim Expands Investigation of Interferon-free Hepatitis C Treatment Regimens to Reach More Patient Types through Presidio Pharmaceuticals Clinical Collaboration
Date:9/10/2013

f investigational HCV compounds that work in complementary ways. The recent collaboration of Boehringer Ingelheim with Presidio Pharmaceuticals, Inc. for a Phase 2a clinical study investigating an interferon- and ribavirin-free, all-oral combination is part of the company's continued commitment to discover and develop innovative options for the treatment of HCV.

STARTVerso® and HCVerso® are registered service marks of Boehringer Ingelheim International GmbH.

Hepatitis C is a blood-born infectious disease and a leading cause of chronic liver disease, transplant and failure that affects as many as 150 million people globally. In the United States, an estimated 4.1 million Americans have been infected with HCV, of which approximately 3.2 million have chronic HCV infection. Since 1999 there has been a significant increase in deaths due to chronic HCV, which accounts for 10,000 -12,000 deaths in the United States per year.

About Boehringer Ingelheim
Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 140 affiliates and more than 46,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.

Social responsibility is a central element of Boehringer Ingelheim's culture. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global o
'/>"/>

SOURCE Boehringer Ingelheim
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Boehringer Ingelheim Pharmaceuticals, Inc. Statement on RE-ALIGN Data
2. Boehringer Ingelheim Announces Agreement to Study Real-World Use of Oral Anticoagulants
3. Boehringer Ingelheim Renews and Expands License to NextBio Research Platform
4. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company Statement on the ADA Request for Independent Review of Incretin-Based Therapies
5. Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference
6. Boehringer Ingelheim Presents Progression-Free Survival Data for Investigational Afatinib and Nintedanib in Advanced NSCLC
7. ASCO 2013: Boehringer Ingelheim to Present Data Across Multiple Cancers, Including Different Treatment Settings for Advanced NSCLC
8. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company launch educational campaign about emerging science in type 2 diabetes
9. Boehringer Ingelheim to Announce Pivotal Phase 3 Hepatitis C Data at the International Liver Congress
10. European Medicines Agency accepts marketing authorization application for Boehringer Ingelheim and Eli Lilly and Companys empagliflozin*, an investigational type 2 diabetes treatment
11. Boehringer Ingelheim and Eli Lilly and Company submit new drug application to FDA for empagliflozin, an investigational type 2 diabetes treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Inc. (NASDAQ: CYBX ), a global leader in ... announced it will participate in the 33 rd  Annual ... San Francisco . Dan ... at 11:00 AM Pacific Time.  A live audio webcast of ... Relations link on the Cyberonics home page at www.cyberonics.com ...
(Date:12/22/2014)... SAN DIEGO , Dec. 22, 2014  Pfenex ... Px563L, Pfenex,s recombinant anthrax vaccine, has been filed and ... additional funding provided by the Department of Health and ... Development Authority (BARDA). "We are extremely pleased ... anthrax vaccine, Px563L.  This represents a significant milestone in ...
(Date:12/19/2014)... 2014  Newport Corporation (NASDAQ: NEWP ... joined the company,s Board of Directors.  Dr. Kadia ... director of Evans Analytical Group, a leading global ... services to companies in a wide range of ... Analytical Group, Dr. Kadia spent nine years with ...
Breaking Medicine Technology:Pfenex Announces Active IND and Additional BARDA Funding for Recombinant Anthrax Vaccine Program, Px563L 2Pfenex Announces Active IND and Additional BARDA Funding for Recombinant Anthrax Vaccine Program, Px563L 3Siddhartha Kadia, Ph.D. Joins Board of Directors of Newport Corporation 2
(Date:12/22/2014)... December 22, 2014 As early as ... can present in the form of “jowls." The dreaded ... start of the marionette line or smile lines. Aging ... diligent skincare, but as the deep facial tissues descend, ... all synthetic fillers that can be used under the ...
(Date:12/22/2014)... 22, 2014 On December 22, 2014, ... Pastor Gordon Cashwell for an episode to celebrate Christmas. ... “Why is it so important to you that we ... replies, “We all should respect who Jesus was. I ... on Christian beliefs. That means that on Jesus’ birthday ...
(Date:12/22/2014)... Physicians in China are most eagerly ... of non-Hodgkin’s lymphoma (NHL), according to a new report ... consulting firm. MabThera is the only biologic available to ... form of NHL. , According to Kantar Health’s report, ... of NHL in China has been growing and is ...
(Date:12/22/2014)... 22, 2014 Give a loved one ... gift of health and vitality. , For a limited ... top-selling anti-aging formulas in special Holiday Wellness gift packages ... , Each bottle contains cutting-edge, proven nutritional support ... work as well as we age. , ...
(Date:12/22/2014)... December 22, 2014 7,178 small business ... of Black Friday shopping and opted instead to join ... education company, for their 5th annual “Black Friday Boot ... just $7 to attend the 5 hour online training ... promptly donated to support two Central Texas based charities ...
Breaking Medicine News(10 mins):Health News:Sam Rizk, MD, FACS, Introduces Rapid Recovery Facelift 2Health News:My Positive Perspective Celebrates Christmas With an Event to Celebrate the Birthday of Jesus 2Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 2Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 3Health News:You Still Have Time to Give the Gift of Health and Vitality to a Mature Loved One 2Health News:Austin Company Digital Marketer Raises 100K to Fight Childhood Cancer 2Health News:Austin Company Digital Marketer Raises 100K to Fight Childhood Cancer 3
... year, approximately 4,500 children in America are diagnosed with leukemia, ... cancer of the blood, it is the most common cancer ... of 10 cases of childhood leukemia, so parents can still ... Izraeli of Tel Aviv University,s Sackler School of Medicine and ...
... with America,s kids, , TUESDAY, July 28 (HealthDay News) -- ... tag of $147 billion per year in direct medical costs, ... at a national conference Tuesday in Washington, DC. , "To ... that all cancers combined cost our health care system $93 ...
... , CHICAGO, July 28 Underscoring the need for ... Association (AMA) is running an ad today emphasizing common ground on health ... The AMA ad runs nationally today in the Chicago Tribune , ... Online advertising will run in various medical trade publications. ...
... , LEBANON, Tenn., July 28 Health Connect Partners, ... has been named the title sponsor of its 2009 Fall Hospital ... Conference is expecting up to 200 directors of pharmacy from some ... addition to educational sessions led by healthcare industry experts, the Hospital ...
... , , FRIENDSWOOD, Texas, ... which develops, manages and owns faith-based senior living facilities, today announced ... Inc. for the development of a new senior living facility in ... Heights , an 82-unit, $10 million senior living facility, should be ...
... , ANN ARBOR, Mich., July 28 ... were at greater risk for a wide range of medical conditions than ... , The study analyzed de-identified insurance claims for more than ... and an interactive graphic charting bipolar patients, risk of comorbid disorders ...
Cached Medicine News:Health News:New drug for children with high-risk leukemia 2Health News:More Can Be Done to Slow Obesity's Toll on Health: Experts 2Health News:More Can Be Done to Slow Obesity's Toll on Health: Experts 3Health News:More Can Be Done to Slow Obesity's Toll on Health: Experts 4Health News:New AMA Ad Emphasizes Common Ground on Health Reform, Shares Vision to Fix Broken System 2Health News:Cardinal Health Announced as Title Sponsor of the Health Connect Partners' 2009 Fall Hospital Pharmacy Conference 2Health News:TrinityCare Senior Living Announces Funding Agreement for Fifth Senior Living Facility 2Health News:TrinityCare Senior Living Announces Funding Agreement for Fifth Senior Living Facility 3Health News:TrinityCare Senior Living Announces Funding Agreement for Fifth Senior Living Facility 4Health News:Patients With Bipolar Disorder at Increased Risk for Wide Range of Health Problems, Thomson Reuters Study Finds 2
Pediatric size. Loops retract lids. Polished finish....
Open ring design with shaft angled at 45 degrees. Blunt teeth. Round knurled handle with dull finish....
Fixation ring with atraumatic teeth provides excellent stabilization and pressure on globe. Round knurled handle with dull finish....
... Designed to fixate the eye ... two-sided ring can easily be ... or smooth side on the ... to the eye to increase ...
Medicine Products: